Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

recordati rare diseases - betaine vatnsfrítt - homocystinuria - Önnur meltingarvegi og efnaskipti vörur, - adjunctive treatment of homocystinuria, involving deficiencies or defects in:cystathionine beta-synthase (cbs);5,10-methylene-tetrahydrofolate reductase (mthfr);cobalamin cofactor metabolism (cbl). cystadane should be used as supplement to other therapies such as vitamin b6 (pyridoxine), vitamin b12 (cobalamin), folate and a specific diet.

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

serb sa - betaine - homocystinuria - Önnur meltingarvegi og efnaskipti vörur, - amversio is indicated as adjunctive treatment of homocystinuria, involving deficiencies or defects in:•         cystathionine beta-synthase (cbs),•         5,10 methylene tetrahydrofolate reductase (mthfr),•         cobalamin cofactor metabolism (cbl).

Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf - letrozolum inn - filmuhúðuð tafla - 2,5 mg

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

novartis europharm limited - nepafenak - pain, postoperative; ophthalmologic surgical procedures - augnlækningar - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf - anastrozolum inn - filmuhúðuð tafla - 1 mg

Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

medochemie limited - modafinilum inn - tafla - 100 mg

Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf - sevelamerum karbónat - filmuhúðuð tafla - 800 mg

Իսլանդիա - իսլանդերեն - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf. - solifenacinum súkkínat; tamsulosinum hýdróklóríð - tafla með breyttan losunarhraða - 6 mg/0,4 mg

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

immedica pharma ab - járn phenylbutyrate - ornithine carbamoyltransferase deficiency disease; citrullinemia; carbamoyl-phosphate synthase i deficiency disease - Önnur meltingarvegi og efnaskipti vörur, - ammonaps er fram eins og venjulega meðferð í langvarandi stjórnun súrefnismettun hringrás vandamál, þar munar carbamylphosphate lígasa, tilfærslu rna orargininosuccinate lígasa. Það er ætlað í alla sjúklinga með nýbura-upphaf kynningu (heill ensím galla, kynna innan fyrsta 28 daga af lífi). Það er einnig ætlað í sjúklinga með seint-upphaf sjúkdómur(hluta ensím galla, kynna eftir fyrsta mánuðinn líf) sem hafa sögu af hyperammonaemic heilabólgu.

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

mylan pharmaceuticals limited - rasagílín tartrat - parkinsonsveiki - anti-parkinsonslyf - rasagilín mylan er ætlað til meðferðar við sjálfvakta parkinsonsveiki (pd) sem einlyfjameðferð (án levódópa) eða sem viðbótarmeðferð (með levodopa) hjá sjúklingum með skammtahreyfingar.